Related Experiment Video

Updated: Feb 12, 2026

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K

Diverse Targeted Approaches to Battle Multidrug Resistance in Cancer

Nagula Shankaraiah1, Shalini Nekkanti1, Ojaswitha Ommi1

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India.

Current Medicinal Chemistry
|April 12, 2018
PubMed

Insights

Cancer drug resistance reduces treatment effectiveness. Understanding multidrug resistance (MDR) mechanisms and tumor factors helps tailor therapies for better patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer therapies often fail due to acquired drug resistance.
  • Tumor cells develop mechanisms to survive and evade drug effects.
  • Multidrug resistance (MDR) is a significant challenge in cancer treatment.

Purpose of the Study:

  • To review the molecular and biochemical mechanisms underlying MDR.
  • To explore tumor-associated factors contributing to drug resistance.
  • To guide the rational selection of cancer treatment strategies based on MDR insights.

Main Methods:

  • Literature review of studies on cancer drug resistance.
  • Analysis of molecular pathways and signaling processes involved in MDR.
  • Examination of tumor-specific factors influencing therapeutic response.

Main Results:

  • Various molecular and biochemical mechanisms contribute to MDR.
  • Specific tumor-associated factors play a crucial role in resistance development.
  • Understanding these factors is key to overcoming treatment limitations.

Conclusions:

  • Elucidating MDR mechanisms and tumor factors is vital for improving cancer therapy.
  • Personalized treatment regimens based on resistance profiles can enhance efficacy.
  • Targeting MDR pathways offers a promising strategy for better patient outcomes.
Keywords:
Alternative kinase inhibitorsAntibody-drug conjugatesMultidrug resistanceSiRNAanticancersmall molecules.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.6K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cell Diversity01:13

Cell Diversity

The concept of a cell started with microscopic observations of dead cork tissue by Robert Hooke in 1665. Hooke coined the term "cell" based on the resemblance of the small subdivisions in the cork to the rooms that monks inhabited, called cells. About ten years later, Antonie van Leeuwenhoek became the first person to observe the living and moving cells under a microscope. In the century that followed, the theory that cells represented the basic unit of life developed.
Multicellular...
5.2K
Diversity of Archaea II01:24

Diversity of Archaea II

Archaea, one of the three domains of life, exhibit remarkable diversity and adaptability, thriving in both extreme and moderate environments. Historically, most identified archaea have been classified into two major phyla: Euryarchaeota and Crenarchaeota. However, recent molecular studies have expanded this classification to include three additional phyla: Thaumarchaeota, Nanoarchaeota, and Korarchaeota, each exhibiting unique characteristics and ecological roles.Thaumarchaeota: Mesophiles...
548
Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
1.2K
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
1.2K